Only half of adults in their early 50s received a recommended screening test for colorectal cancer in 2018, according to a new Vital Signs report from the Centers for Disease Control and Prevention. The U.S. Preventive Services Task Force recommends a colonoscopy or other colorectal cancer screening test for adults aged 50-75 who are at average risk, such as those who do not have a personal or family history of colorectal cancer or polyps. In 2018, screening in the recommended age group increased with age. It was lowest among those lacking health insurance or a regular care provider, and highest among those whose annual household income was $75,000 or more. Screening prevalence by state was highest in Massachusetts (76.5%) and lowest in Wyoming (57.8%). Colorectal cancer is the second leading cause of cancer death in the United States.

Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…